Genenta Science SpA ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Free Cash Flow -$8.1MTTM through 31 Dec 2025
Margins
| Current |
|---|
Returns
-29.9%ROE
-20.5%ROA
Balance Sheet Health
Current Ratio14.16x
Cash & Equivalents$5.5M
Quality Metrics
Altman Z-Score-0.66
Piotroski F-Score2 / 9
Multi-Year Trend
Diluted EPSFY2025: $-0.33
Dividend
No dividend
Capital Allocation
R&D Spend$2.7M
Segment Performance
No segment data available.
Financials converted at 0.8513 from EUR.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.